9969 fundamentals
An in-depth look to INNOCARE PHARMA LTD operating, investing, and financing activities
9969 free cash flow for Q2 24 is -180.05 M HKD. For 2023, 9969 free cash flow was -885.59 M HKD and operating cash flow was -604.19 M HKD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM